The landscape of immune checkpoint inhibitor therapy in advanced lung cancer
Chengdi Wang(Sichuan University), Yalun Li(Sichuan University), Lujia Song(Sichuan University), Yuxuan Xiao(Albany Medical Center Hospital), Jingwei Li(Kunming University), Jiayang Wu(Sichuan University), Hanlin Gong(Harbin Institute of Technology), Qiran Zhang(Fudan University)
Cited by 25
Related Papers
Lactoferrin-conjugated PEG–PLA nanoparticles with improved brain delivery: In vitro and in vivo evaluations
|Journal of Controlled Release|2008|349
The heterogeneous immune landscape between lung adenocarcinoma and squamous carcinoma revealed by single-cell RNA sequencing
|Signal Transduction and Targeted Therapy|2022|218
Tea leaf-derived exosome-like nanotherapeutics retard breast tumor growth by pro-apoptosis and microbiota modulation
|Journal of Nanobiotechnology|2023|178
Characterization of distinct circular RNA signatures in solid tumors
|Molecular Cancer|2022|84
Diagnostic efficacy of PET and PET/CT for recurrent lung cancer: a meta-analysis
|Acta Radiologica|2013|61